TWST
TWST
NASDAQ · Biotechnology

Twist Bioscience Corp

$48.64
+1.15 (+2.42%)
As of Mar 25, 9:59 PM ET ·
Financial Highlights (FY 2026)
Revenue
386.04M
Net Income
-79,625,511
Gross Margin
50.7%
Profit Margin
-20.6%
Rev Growth
+22.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 50.7% 50.7% 64.6% 64.6%
Operating Margin -36.2% -32.6% -18.1% -16.3%
Profit Margin -20.6% -19.6% -22.5% -21.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 386.04M 314.49M 1.46B 1.26B
Gross Profit 195.80M 159.51M 939.97M 813.51M
Operating Income -139,668,146 -102,404,343 -262,966,088 -205,568,672
Net Income -79,625,511 -58,381,230 -327,760,773 -264,222,817
Gross Margin 50.7% 50.7% 64.6% 64.6%
Operating Margin -36.2% -32.6% -18.1% -16.3%
Profit Margin -20.6% -19.6% -22.5% -21.0%
Rev Growth +22.8% +22.8% +7.9% -1.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 416.12M 410.07M
Total Equity 1.48B 1.61B
D/E Ratio 0.28 0.25
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -65,057,850 -50,350,270 -326,178,396 -311,202,322
Free Cash Flow -164,017,098 -221,326,881